Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Editas Medicine announced two poster presentations at the ESGCT 33rd Annual Congress, held October 27-30, 2026, in Hamburg, Germany. The posters cover targeted LNP delivery for in vivo CAR-T cell generation and a GMP-ready manufacturing platform for targeted LNP therapeutics, both presented by Harry An on October 28.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.